Oh God, I love this one. I've got a real winner on the other end here. He has to actually quote his college credentials to a stranger. I bet you have a small penis and are insecure about it and half a dozen other things. You see, psychology is my game. You are the patient.
I know your type through and through.
As for Biogen, good luck. You'll need it.
Looks like your lack of insight is bubbling through Oscar. Can't blame you given the losses you're going to face tomorrow.
As to insulting me
I've done very well investing over the past 10 years
top 10 U.K medical school
Graduated top 10% of year with Honours
Youngest Consultant in year
Not Harvard but you'd be lucky to get me to treat you and after tomorrow won't be able to afford it anyway.
You are quite wrong. Tomorrow will be a very strong day, and the future of T, and both BIIB and ELAN, just got much brighter. Like it or not, MS is a horrible disease in dire need of medical help, and T provides it very well. Labelling and limits for immunosuppresent patients will not unduly restrict T. Just watch.
There is no way in hell this drug is coming back in any meaningful way if any way at all. If you knew how Tysabri worked, you'd know that is the risk is too great for any doctor to ever prescribe. It basically disables part of your immune system............Which is why complication arose......as it was explained to me.
The news results seem to indicate the efficacy of the drug.
It would seem the real task if figuring out how to determine those patients at risk from the various side effects.
Would appreciate hearing some informed medical opinions.